Last $0.30 USD
Change Today -0.0677 / -18.41%
Volume 796.4K
RGDX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - response genetics inc (RGDX)

Name (Connections)Board RelationshipsTitleKey Developments
Kirk Calhoun CPA 22 RelationshipsLead Director and Member of Compensation CommitteeResponse Genetics, Inc announced delayed 10-Q filing
08/14/09
David Wurzer CPA 10 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit CommitteeResponse Genetics, Inc announced delayed annual 10-K filing
04/2/12
Sam Chawla 19 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - response genetics inc (RGDX)

Name (Connections)Board RelationshipsTitle
Kirk Calhoun CPA 22 RelationshipsLead Director and Member of Compensation Committee
Richard van den Broek CFA 31 RelationshipsDirector, Chairman of Nominating & Governance Committee and Member of Compensation Committee
David Wurzer CPA 10 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
RGDX Compensation vs. Industry
576.7K
394.9K
Chief Executive Officer
264.0K
304.2K
Chief Financial Officer
Share price activity for RESPONSE GENETICS INC (RGDX)
52 Week Price Performance
RGDX
Industry Average

Nominating Committee* - response genetics inc (RGDX)

Name (Connections)Board RelationshipsTitleKey Developments
Richard van den Broek CFA 31 RelationshipsDirector, Chairman of Nominating & Governance Committee and Member of Compensation CommitteeResponse Genetics, Inc Appoints Kevin R. Harris as Vice President and Chief Financial Officer
06/17/13
Michael Serruya 26 RelationshipsDirector and Member of Nominating & Governance CommitteeResponse Genetics, Inc. Appoints James Wynne as Vice President, Sales & Marketing
10/1/12
David Schreiber 19 RelationshipsDirector and Member of Nominating & Governance CommitteeResponse Genetics, Inc. Announces Executive Changes
08/21/12

Corporate Governance Committee* - response genetics inc (RGDX)

Name (Connections)Board RelationshipsTitle
David Schreiber 19 RelationshipsLead Director and Member of Compensation Committee
Michael Serruya 26 RelationshipsDirector, Chairman of Nominating & Governance Committee and Member of Compensation Committee
Richard van den Broek CFA 31 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
RGDX and Competitor
Insiders vs. External
Board
14%
86%
Response Genetics, Inc
43%
57%
Neogenomics Inc.
11%
89%
Rosetta Genomics, Ltd.
14%
86%
Cancer Genetics, Inc.
13%
87%
Veracyte, Inc.
29%
71%
Foundation Medicine, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGDX:US $0.30 USD -0.0677

RGDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cancer Genetics Inc $7.17 USD +0.05
Foundation Medicine Inc $23.96 USD -0.03
NeoGenomics Inc $4.15 USD +0.12
Rosetta Genomics Ltd $2.33 USD -0.02
Veracyte Inc $9.27 USD +1.03
View Industry Companies
 

Industry Analysis

RGDX

Industry Average

Valuation RGDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 7.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESPONSE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.